Literature DB >> 24936254

Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

François Chabot1, Alexandre Caron1, Mathieu Laplante1, David H St-Pierre1.   

Abstract

Ghrelin is a 28 amino acid peptide mainly derived from the oxyntic gland of the stomach. Both acylated (AG) and unacylated (UAG) forms of ghrelin are found in the circulation. Initially, AG was considered as the only bioactive form of ghrelin. However, recent advances indicate that both AG and UAG exert distinct and common effects in organisms. Soon after its discovery, ghrelin was shown to promote appetite and adiposity in animal and human models. In response to these anabolic effects, an impressive number of elements have suggested the influence of ghrelin on the regulation of metabolic functions and the development of obesity-related disorders. However, due to the complexity of its biochemical nature and the physiological processes it governs, some of the effects of ghrelin are still debated in the literature. Evidence suggests that ghrelin influences glucose homeostasis through the modulation of insulin secretion and insulin receptor signaling. On the other hand, insulin was also shown to influence circulating levels of ghrelin. Here, we review the relationship between ghrelin and insulin and we describe the impact of this interaction on the modulation of glucose homeostasis.

Entities:  

Keywords:  Acylated ghrelin; Glucose homeostasis; Insulin receptor signalling; Insulin secretion; Unacylated ghrelin; β-cell functions

Year:  2014        PMID: 24936254      PMCID: PMC4058737          DOI: 10.4239/wjd.v5.i3.328

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  152 in total

1.  AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes.

Authors:  Yossi Dagon; Yosefa Avraham; Elliot M Berry
Journal:  Biochem Biophys Res Commun       Date:  2005-12-06       Impact factor: 3.575

2.  IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion.

Authors:  Asako Doi; Takeshi Shono; Masahiro Nishi; Hiroto Furuta; Hideyuki Sasaki; Kishio Nanjo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

3.  Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients.

Authors:  P Alvarez-Castro; M L Isidro; J García-Buela; C Dieguez; F F Casanueva; F Cordido
Journal:  Diabetes Obes Metab       Date:  2006-09       Impact factor: 6.577

Review 4.  Ghrelin in Type 2 diabetes mellitus and metabolic syndrome.

Authors:  Olavi Ukkola
Journal:  Mol Cell Endocrinol       Date:  2011-03-23       Impact factor: 4.102

5.  Dose-dependent inhibition by ghrelin of insulin secretion in the mouse.

Authors:  Martina Kvist Reimer; Giovanni Pacini; Bo Ahrén
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

6.  Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

Authors:  Akira Katsuki; Hideki Urakawa; Esteban C Gabazza; Shuichi Murashima; Kaname Nakatani; Kenji Togashi; Yutaka Yano; Yukihiko Adachi; Yasuhiro Sumida
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

7.  Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage.

Authors:  Pierre Miegueu; Katherine Cianflone; Denis Richard; David H St-Pierre
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-19       Impact factor: 4.310

8.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

9.  Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome.

Authors:  Rocco Barazzoni; Michela Zanetti; Clara Ferreira; Pierandrea Vinci; Alessia Pirulli; Mariapia Mucci; Franca Dore; Maurizio Fonda; Beniamino Ciocchi; Luigi Cattin; Gianfranco Guarnieri
Journal:  J Clin Endocrinol Metab       Date:  2007-07-24       Impact factor: 5.958

10.  Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin.

Authors:  Guillaume de Lartigue; Rod Dimaline; Andrea Varro; Graham J Dockray
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

View more
  26 in total

1.  Blunted suppression of acyl-ghrelin in response to fructose ingestion in obese adolescents: the role of insulin resistance.

Authors:  Michelle Van Name; Cosimo Giannini; Nicola Santoro; Ania M Jastreboff; Jessica Kubat; Fangyong Li; Romy Kursawe; Mary Savoye; Elvira Duran; James Dziura; Rajita Sinha; Robert S Sherwin; Gary Cline; Sonia Caprio
Journal:  Obesity (Silver Spring)       Date:  2015-02-03       Impact factor: 5.002

2.  Supplementation with eicosapentaenoic and docosahexaenoic acids in late gestation in ewes changes adipose tissue gene expression in the ewe and growth and plasma concentration of ghrelin in the offspring1.

Authors:  Kirsten R Nickles; Lauren Hamer; Danielle N Coleman; Alejandro E Relling
Journal:  J Anim Sci       Date:  2019-05-30       Impact factor: 3.159

Review 3.  Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders.

Authors:  Milind V Masule; Sumit Rathod; Yogeeta Agrawal; Chandragouda R Patil; Kartik T Nakhate; Shreesh Ojha; Sameer N Goyal; Umesh B Mahajan
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-06-13

4.  Sleep Disturbance and Changes in Energy Intake and Body Composition During Weight Loss in the POUNDS Lost Trial.

Authors:  Ang Li; Xiang Li; Tao Zhou; Hao Ma; Yoriko Heianza; Donald A Williamson; Steven R Smith; George A Bray; Frank M Sacks; Lu Qi
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

5.  Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.

Authors:  Pinar Gumus Balikcioglu; Metin Balikcioglu; Michael J Muehlbauer; Jonathan Q Purnell; David Broadhurst; Michael Freemark; Andrea M Haqq
Journal:  J Clin Endocrinol Metab       Date:  2015-08-10       Impact factor: 5.958

Review 6.  Ghrelin - Physiological Functions and Regulation.

Authors:  Mona Mohamed Ibrahim Abdalla
Journal:  Eur Endocrinol       Date:  2015-08-19

7.  Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP-1, and insulin secretion.

Authors:  Ayse G Zengul; Sarah Et Hoover; Paula C Chandler-Laney
Journal:  Pediatr Obes       Date:  2020-11-25       Impact factor: 4.000

8.  Genetic determinants of metabolic biomarkers and their associations with cardiometabolic traits in Hispanic/Latino adolescents.

Authors:  Daeeun Kim; Anne E Justice; Geetha Chittoor; Estela Blanco; Raquel Burrows; Mariaelisa Graff; Annie Green Howard; Yujie Wang; Rebecca Rohde; Victoria L Buchanan; V Saroja Voruganti; Marcio Almeida; Juan Peralta; Donna M Lehman; Joanne E Curran; Anthony G Comuzzie; Ravindranath Duggirala; John Blangero; Cecilia Albala; José L Santos; Bárbara Angel; Betsy Lozoff; Sheila Gahagan; Kari E North
Journal:  Pediatr Res       Date:  2021-10-13       Impact factor: 3.953

9.  Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse model.

Authors:  Nicolas Kunath; Thomas van Groen; David B Allison; Ashish Kumar; Monique Dozier-Sharpe; Inga Kadish
Journal:  Sci Rep       Date:  2015-06-19       Impact factor: 4.379

10.  Influence of Helicobacter pylori Infection on Metabolic Syndrome in Old Chinese People.

Authors:  Wen Yang; Cunfu Xuan
Journal:  Gastroenterol Res Pract       Date:  2016-06-27       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.